These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 30536793)

  • 1. Quality, bioactivity study, and preclinical acute toxicity, safety pharmacology evaluation of PEGylated recombinant human endostatin (M
    Guo L; Geng X; Liu L; Miao Y; Lin Z; Yu M; Fu Y; Liu L; Li B; Luo Y
    J Biochem Mol Toxicol; 2019 Mar; 33(3):e22257. PubMed ID: 30536793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-clinical Efficacy and Safety Pharmacology of PEGylated Recombinant Human Endostatin.
    Guo L; Hua L; Hu B; Wang J
    Curr Mol Med; 2024; 24(3):389-396. PubMed ID: 36999708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-clinical toxicokinetics and safety study of M2ES, a PEGylated recombinant human endostatin, in rhesus monkeys.
    Guo L; Geng X; Chen Y; Qi F; Liu L; Miao Y; Lin Z; Yu M; Li Z; Fu Y; Li B; Luo Y
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):512-23. PubMed ID: 24878240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically engineered endostatin-lidamycin fusion proteins effectively inhibit tumor growth and metastasis.
    Jiang WG; Lu XA; Shang BY; Fu Y; Zhang SH; Zhou D; Li L; Li Y; Luo Y; Zhen YS
    BMC Cancer; 2013 Oct; 13():479. PubMed ID: 24128285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biophysical and biological characterization of PEGylated recombinant human endostatin.
    Guo L; Xu B; Zhou D; Chang G; Fu Y; Liu L; Luo Y
    Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):920-927. PubMed ID: 31278773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pre-clinical safety study of PEGylated recombinant human endostatin (M
    Geng X; Guo L; Liu L; Wang C; Peng Q; Qi W; Sun L; Liu X; Miao Y; Lin Z; Fu Y; Luo Y; Li B
    Regul Toxicol Pharmacol; 2018 Jun; 95():190-197. PubMed ID: 29580973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog.
    Wang S; Fu Y; Luo Y
    Chin J Cancer; 2016 Jan; 35():14. PubMed ID: 26792627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of PEGylated recombinant human endostatin in rhesus monkeys.
    Guo L; Li Z; Xu B; Yu M; Fu Y; Liu L; Wang J; Luo Y
    Life Sci; 2019 Dec; 238():116967. PubMed ID: 31626794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactivity, pharmacokinetics, and immunogenicity assays in preclinical and clinical trials for recombinant human endostatin.
    Hu B; Zhu HW; Zhu LP; Li C; Rong ZG; Xu JM; Wu ZW; Wang JJ; Xu GX
    Acta Pharmacol Sin; 2008 Nov; 29(11):1357-69. PubMed ID: 18954531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endostar, a modified recombinant human endostatin, exhibits synergistic effects with dexamethasone on angiogenesis and hepatoma growth.
    Li XQ; Shang BY; Wang DC; Zhang SH; Wu SY; Zhen YS
    Cancer Lett; 2011 Feb; 301(2):212-20. PubMed ID: 21216091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endostar, a recombined humanized endostatin, enhances the radioresponse for human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts in mice.
    Wen QL; Meng MB; Yang B; Tu LL; Jia L; Zhou L; Xu Y; Lu Y
    Cancer Sci; 2009 Aug; 100(8):1510-9. PubMed ID: 19459845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of tumor growth and metastasis via local administration of recombinant human endostatin adenovirus].
    Wu Y; Yang L; Zhao X; Su JM; Hu B; Liu JY; Niu T; Luo Y; Li Q; Wei YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):557-61. PubMed ID: 15583981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
    Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
    PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells.
    Zhuo W; Luo C; Wang X; Song X; Fu Y; Luo Y
    J Pathol; 2010 Nov; 222(3):249-60. PubMed ID: 20814900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human recombinant endostatin Endostar attenuates hepatic sinusoidal endothelial cell capillarization in CCl4‑induced fibrosis in mice.
    You Q; Kong LJ; Li FD; Wang HY; Liu DG; Pei FH; Song JT; Xu J; Chen J
    Mol Med Rep; 2015 Oct; 12(4):5594-600. PubMed ID: 26239504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endostar, a recently introduced recombinant human endostatin, inhibits proliferation and migration through regulating growth factors, adhesion factors and inflammatory mediators in choroid-retinal endothelial cells.
    Xu W; Ye P; Li Z; Shi J; Wang W; Yao K
    Mol Biol (Mosk); 2010; 44(4):664-70. PubMed ID: 20873226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors.
    Thomas JP; Arzoomanian RZ; Alberti D; Marnocha R; Lee F; Friedl A; Tutsch K; Dresen A; Geiger P; Pluda J; Fogler W; Schiller JH; Wilding G
    J Clin Oncol; 2003 Jan; 21(2):223-31. PubMed ID: 12525513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancer.
    Hansma AH; Broxterman HJ; van der Horst I; Yuana Y; Boven E; Giaccone G; Pinedo HM; Hoekman K
    Ann Oncol; 2005 Oct; 16(10):1695-701. PubMed ID: 16012180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effect of migration-inducing gene-7-shRNA recombinant retrovirus combined with endostatin on growth and metastasis of hepatoma xenograft].
    Qu B; Chen GN; Sheng GN; Yu F; Lyu Q; Gu YJ; Guo L; Lyu Y
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):681-686. PubMed ID: 27788725
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic efficacy of recombinant human endostatin combined with chemotherapeutics in mice-transplanted tumors.
    Zhu LP; Xing J; Wang QX; Kou L; Li C; Hu B; Wu ZW; Wang JJ; Xu GX
    Eur J Pharmacol; 2009 Sep; 617(1-3):23-7. PubMed ID: 19615993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.